Fabrication of Engineered Vascular Flaps Using 3D Printing Technologies
May 19th, 2022
Engineered flaps require an incorporated functional vascular network. In this protocol, we present a method of fabricating a 3D printed tissue flap containing a hierarchical vascular network and its direct microsurgical anastomoses to rat femoral artery.
Overview
This protocol outlines a method for creating a 3D printed tissue flap with a hierarchical vascular network, enabling direct microsurgical anastomoses to the rat femoral artery. The approach combines advanced 3D printing techniques to facilitate the study of blood vessel behavior during in vivo integration.
Key Study Components
Area of Science
- Tissue Engineering
- Vascular Biology
- 3D Bioprinting
Background
- Engineered flaps require functional vascular networks for successful integration.
- Current methods lack efficient techniques for creating vascularized tissue constructs.
- This study aims to address these limitations through innovative 3D printing methods.
- Understanding blood vessel behavior is crucial for developing effective tissue engineering strategies.
Purpose of Study
- To fabricate a 3D printed tissue flap with a hierarchical vascular network.
- To enable direct anastomosis with host blood vessels.
- To provide a platform for studying tissue development and integration.
Methods Used
- Combination of micro and mesoscale 3D printing techniques.
- Preparation of polymer solutions and cell suspensions for bioprinting.
- Use of lyophilization and solvent removal to create scaffolds.
- Microsurgical techniques for anastomosing the engineered flaps to host vessels.
Main Results
- Successful fabrication of vascularized tissue flaps with hierarchical networks.
- Demonstrated feasibility of direct anastomosis to the rat femoral artery.
- Provided insights into blood vessel behavior during in vivo integration.
- Established a foundation for future studies on tissue-specific cell incorporation.
Conclusions
- The developed method enhances the potential for treating large tissue defects.
- It opens avenues for further research on vascularized tissue constructs.
- This approach can be adapted for various bioink and support material evaluations.
Frequently Asked Questions
Executive Industry Relevance
Engineering hierarchical vascular networks using 3D bioprinting addresses a critical bottleneck in creating functional, implantable tissues for regenerative medicine and reconstructive applications. This approach enables the fabrication of complex, perfusable tissue constructs that can be directly integrated with host vasculature, supporting translational research and preclinical model development. The method enhances predictive confidence in tissue integration and vascularization, informing risk-adjusted portfolio decisions in advanced tissue engineering pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of vascular integration and tissue perfusion in engineered constructs.
- Supports biological de-risking by modeling vessel anastomosis and network maturation.
- Facilitates predictive assessment of tissue viability and integration potential.
Screening & Assay Development
- Provides standardized, reproducible vascularized tissue platforms for compound evaluation.
- Enables quantitative assessment of endothelial and support cell behavior in 3D environments.
- Supports scalability and platform reuse for diverse bioink and cell type screening.
Translational & Preclinical Research
- Aligns engineered tissue models with disease-relevant vascularization and integration endpoints.
- Enables continuity from in vitro tissue development to in vivo implantation and perfusion studies.
- Supports risk-adjusted advancement of tissue constructs for reconstructive and regenerative applications.
Pipeline & Workflow Integration
This combined 3D bioprinting and sacrificial mold approach integrates into the discovery-to-preclinical continuum, enabling iterative optimization of vascularized tissue constructs for downstream translational studies.
- Discovery Biology: Supports hypothesis testing on vessel formation, anastomosis, and tissue integration.
- Screening: Delivers reproducible, quantitative outputs on vascular network assembly and cell viability.
- Analytics: Provides imaging and immunostaining readouts for network connectivity and maturation.
- Translational Research: Bridges in vitro tissue engineering with in vivo perfusion and integration models.
- Enterprise Reuse: Offers a modular platform adaptable to various tissue types and vascularization studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in tissue integration and vascular function.
- Operational Value: Standardizes fabrication and assessment of vascularized constructs for reproducibility.
- Strategic Value: Informs go/no-go decisions for tissue engineering programs targeting clinical translation.
- Portfolio Impact: Enables risk-adjusted prioritization of tissue constructs for further development.
Implementation Considerations
- Requires expertise in 3D bioprinting, cell culture, and microsurgical techniques.
- Demands access to extrusion-based bioprinters, imaging, and analytical infrastructure.
- Necessitates cross-team standardization of bioink formulations and scaffold fabrication.
- Adaptable to different cell types and support materials for diverse tissue models.
- Limited by the need for precise control of vascular network architecture and integration.
Biopharma FAQs
Chapters in this video
0:04
Introduction
1:04
Vascular Scaffold Fabrication
1:54
Granular Support Bath Preparation and Incorporation of Endothelial Cells and Support Cells with the Bioink
3:09
Bioprinting Microvascular Networks Using rhCollMA Bioink
6:00
Assembling the Bioprinted Microvascular Network with the Vascular Scaffold to Obtain the Engineered Vascularized Flap
7:12
Results: Representative Images of the Assembled Vascularized Flap
7:59
Conclusion
